Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


The global fight against hepatitis B is benefitting some parts of the world more than others

Cartoon of two figures on a see-saw that is made of a hypodermic needle

Illustration: Chiara Zarmati

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 603, S58-S59 (2022)


This article is part of Nature Outlook: Hepatitis B, an editorially independent supplement produced with the financial support of third parties. About this content.


  1. Stockdale, A. J. et al. J. Infect. Dis. (2021).

    Article  Google Scholar 

  2. Kane, M. A. et al. Vaccine 31, J15–J20 (2013).

    Article  PubMed  Google Scholar 

  3. Qu, C., Duan, Z., Chen, K. & Zou, H. Hepatoma Res. 3, 228–240 (2017).

    Article  Google Scholar 

  4. Tordrup, D. et al. Lancet Glob. Health 7, e1180-e1188 (2019).

    Article  PubMed  Google Scholar 

  5. Tordrup, D. et al. Value Health 23, 1552–1560 (2020).

    Article  PubMed  Google Scholar 

  6. Toy, M., Hutton, D. W. & So, S. Health Aff. 37, 1033–1040 (2018).

    Article  Google Scholar 

  7. Toy, M. et al. Clin. Infect. Dis. 74, 210–217 (2022).

    Article  PubMed  Google Scholar 

Download references


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links